Managing cannabis impairment risks at work
With a referendum on the legalisation of cannabis in September 2020 now is a timely opportunity for Forum members to proactively review and assess the sufficiency of their approach to managing the risk of impairment caused by drugs and alcohol.
Impairment is a significant workplace risk. The Forum is not taking a formal position on the referendum question itself – our priority is supporting you to manage the risk of impairment, not simply one substance.
We encourage all businesses to use the cannabis debate as an opportunity to reflect, refine and refocus their current approaches to managing impairment risks at work – from cannabis, as well as other drugs and fatigue.
Lessons from Canada
Watch our two-part webinar series with the Canadian Centre for Substance Use and Addiction, focusing on the legalisation of cannabis and its impact on impairment at work.
Part one: Legalisation of cannabis in Canada and putting together an impairment policy.
Part two: A deep-dive into cannabis, other sources of impairment and what employers can learn from Canada.
We have put together a series of resources to support organisations to focus on what matters around managing the risk of impairment, for a safer and healthier workplace. These are:
- Reflective guide: Focusing on what matters - Managing cannabis impairment risks at work
Preparing for legalisation in Canada and what NZ businesses could learn: The Forum speaks to the Canadian Centre for Substance Use and Addiction
Cannabis use and perceptions about workplace use in Canada: The Forum speaks to the Institute of Work and Health in Canada about how cannabis use at work has changed, if at all, since legalisation in Canada in 2018.